Antitumor agent-3 is primarily utilized in cancer research and treatment due to its potential to inhibit the growth of tumor cells. It is often studied for its efficacy in targeting specific cancer pathways, making it a candidate for developing targeted therapies. Researchers explore its role in inducing apoptosis (programmed cell death) in malignant cells, which is crucial for reducing tumor size and preventing metastasis. Additionally, it is investigated in combination with other chemotherapeutic agents to enhance treatment outcomes and reduce side effects. Its application extends to preclinical studies, where it is tested on various cancer models to understand its mechanisms and optimize its therapeutic potential.